SOURCE: Sichenzia Ross Friedman Ference LLP

Sichenzia Ross Friedman Ference LLP

December 23, 2013 08:00 ET

Sichenzia Ross Friedman Ference LLP Assists in Major Branded and Generic Pharmaceutical Industry Private Equity Sale

A Team of Lawyers Led by Partners Harvey Kesner and Tom Rose Assisted Sellers in a Transaction Involving Sale of a Controlling Interest in Vertical Pharmaceuticals and Trigen Laboratories to an Investor Group Led by Avista Capital

NEW YORK, NY--(Marketwired - December 23, 2013) - Sichenzia Ross Friedman Ference LLP (SRFF), a leading corporate securities law firm headquartered in New York City, acted as counsel to pharmaceutical companies Vertical Pharmaceuticals and Trigen Laboratories in negotiating the sale of a controlling interest in connection with the bid by Avista Capital Partners. Vertical Pharmaceuticals is a specialty pharmaceutical company engaged in the development, marketing, and distribution of prescription pharmaceuticals and Trigen Laboratories distributes generic drugs.

Mr. Kesner helped to spearhead the recent expansion of SRFF to include experts in intellectual property and drug/FDA licensing who also provided expertise in connection with the transaction. Mr. Kesner stated, "We were pleased our team was able to work with Vertical and Trigen to create great value for its owners by completing this significant transaction with a world-class partner to help grow and evolve their business. Avista is a well-known builder of world-class enterprises in drug development and distribution. Our team was able to work effectively with Avista and their counsel to structure and close this highly complex transaction, relying heavily on our expanded capabilities in the IP/pharma and licensing space."

The SRFF team consisted of senior corporate partners Harvey Kesner and Tom Rose, corporate associates Jeffrey Cahlon and Tara Guarneri-Ferrara, and IP/licensing counsel Franciscus Diaba.

Vertical Pharmaceuticals is focused on branded pharmaceuticals, specializing in women's health, pain management, and respiratory and allergy medications. Its brands include OB Complete, Corvite, ConZip, and Lorzone and are marketed by a dedicated national sales force. Trigen Laboratories, the generic pharmaceutical arm of the Company, markets over 70 unique formulations in the prenatal, hematinic (iron) supplement, and cough/cold remedy markets, with over 30 products currently in its pipeline.

About Sichenzia Ross Friedman Ference LLP

Sichenzia Ross Friedman Ference LLP is a boutique law firm of 42 attorneys based in New York City's financial district. SRFF delivers an unmatched concentration of expertise in corporate and securities law, mergers & acquisitions, IPOs and corporate securities litigation in domestic and international markets. SRFF attorneys invest decades of legal expertise into the entrepreneurial eco-system with clients ranging from start-ups to established, listed companies, private and public entities, investment banks, high net worth investors and over 30 biotech, diagnostic and medical device companies in public and/or private financings. To learn more about SRFF, please visit, follow us on Twitter @srffllp, and join our group on LinkedIn.

Contact Information

  • Media Contact:
    Charles D. Bernstein
    Sichenzia Ross Friedman Ference LLP
    (212) 930-9700